Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer (Q33611502)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jan Erik Varhaug

5

object named as

Jan Erik Varhaug

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Steinar Lundgren

3

object named as

Steinar Lundgren

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Gunnar Mellgren

6

object named as

Gunnar Mellgren

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

7

object named as

Vidar M Steen

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Jennifer Gjerde

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jürgen Geisler

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dagfinn Ekse

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ernst A Lien

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

21 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

313

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Genotype-guided tamoxifen therapy: time to pause for reflection?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Impaired tamoxifen metabolism reduces survival in familial breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

CYP2C19*17 is associated with decreased breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Tamoxifen, hot flashes and recurrence in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Association of tamoxifen (TAM) and TAM metabolite concentrations with self-reported side effects of TAM in women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Long-term exposure to tamoxifen induces hypersensitivity to estradiol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Hormonal effects of aromatase inhibitors: focus on premenopausal effects and interaction with tamoxifen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Basic guide to the mechanisms of antiestrogen action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Steroid absorption and enterohepatic recycling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

21 June 2018

Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment.

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Persistent hot flushes in older postmenopausal women

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Human SULT1A1 gene: copy number differences and functional implications

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Effect of N,N-didesmethyltamoxifen upon DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

17ss-Hydroxysteroid dehydrogenase type 1 as predictor of tamoxifen response in premenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients.

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial.

1 reference

https://api.crossref.org/works/10.1186/1471-2407-10-313

21 January 2018

Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

30 October 2018

Excretion of hydroxylated metabolites of tamoxifen in human bile and urine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

30 October 2018

Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910688

30 October 2018

Influence of tamoxifen and its N-desmethyl and 4-hydroxy metabolites on rat liver microsomal enzymes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of 4-hydroxy-N-desmethyltamoxifen as a metabolite of tamoxifen in human bile

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of 4-hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-related difference in tamoxifen disposition

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in serum estrogen levels in women during tamoxifen therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid on-line profiling of estrogen receptor binding metabolites of tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/20565970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-10-313

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33611502&oldid=2195563986"